-
Taxonomy & unit
-
ratio: %
-
Description
-
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
-
Summary
-
BioNexus Gene Lab Corp quarterly/annual Return On Equity history and growth rate from 2019 to 2023.
- BioNexus Gene Lab Corp Return On Equity for the quarter ending June 30, 2024 was -23.1 %, a 155% decline year-over-year.
- BioNexus Gene Lab Corp annual Return On Equity for 2023 was -33.8 %, a 542% decline from 2022.
- BioNexus Gene Lab Corp annual Return On Equity for 2022 was -5.27 %, a 149% decline from 2021.
- BioNexus Gene Lab Corp annual Return On Equity for 2021 was 10.8 %, a 36.5% decline from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)